RA Capital Management® (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital® to provide seed funding to startups and to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with fewer capital concerns from inception through commercialization.
At RA Capital’s core is its TechAtlas research division, a scientifically trained team that maps out competitive landscapes in a continual effort to put data into context, identify breakthroughs, and originate conviction in new ideas. TechAtlas provides RA Capital’s investment team and portfolio companies with strategic intelligence, market research, and other resources. The team’s understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability.
Investment Management, Healthcare, Biotechnology, Financial Services , Venture Capital, and Lifesciences
RA Capital Management funds and builds healthcare and life science companies and has a growing interest in climate and sustainability technologies.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Colliers Real Estate | Colliers Real Estate | Other 16 Apr 2024 | | |
Deloitte Consulting, audit, Business Consulting and Services | Deloitte Consulting, audit, Business Consulting and Services | Other 16 Apr 2024 | | |
Vertex Pharmaceuticals Biotechnology, Biotechnology Research | Vertex Pharmaceuticals Biotechnology, Biotechnology Research | Other 23 Sep 2020 30 Apr 2024 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 7 Nov 2021 | |